Advance in diagnosis and treatment of adrenocortical tumor
10.3760/cma.j.issn.1674-6090.2016.03.018
- VernacularTitle:肾上腺皮质肿瘤的诊治进展
- Author:
Sai CHOU
;
Yushi ZHANG
- Publication Type:Journal Article
- Keywords:
Adrenocortical tumor;
Adrenal cortex;
Primary aldosteronism;
Subclinical hypercortisolism;
Adrenocortical cancer
- From:
Chinese Journal of Endocrine Surgery
2016;10(3):248-251
- CountryChina
- Language:Chinese
-
Abstract:
Management of adrenocortical tumor are developing vigorously,from diagnostic treatment to precisely therapy with endocrine lab test and radiology examination improving.The prevalence rate of incidental adrenal mass is 7％.Update researches show that surgical treatment is beneficial in subclinical hypercorisolism patients combined with adrenal incidentaloma.Histopathology improves the evaluation of prognosis in primary aldosteronism patients.For adrenocortical cancer patients,mitotane with combination of etoposide,doxorubicin and cisplatin after surgical treatment was recommended,while adjuvant radiotherapy needs more study to conform the efficacy.
